Thomas D. Southgate

461 total citations
16 papers, 361 citations indexed

About

Thomas D. Southgate is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Thomas D. Southgate has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Genetics. Recurrent topics in Thomas D. Southgate's work include Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (3 papers). Thomas D. Southgate is often cited by papers focused on Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (4 papers) and CAR-T cell therapy research (3 papers). Thomas D. Southgate collaborates with scholars based in United Kingdom, United States and Netherlands. Thomas D. Southgate's co-authors include María G. Castro, Paul A. Kingston, Peter L. Stern, Christopher M. Ward, Pedro R. Löwenstein, Leslie J. Fairbairn, Francesca Soncin, Flor M. Pérez-Campo, Catherine L.R. Merry and Helen Spencer and has published in prestigious journals such as PLoS ONE, Molecular Biology of the Cell and Trends in Endocrinology and Metabolism.

In The Last Decade

Thomas D. Southgate

16 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas D. Southgate United Kingdom 11 203 107 105 71 39 16 361
Marsha Pellegrino Italy 13 212 1.0× 169 1.6× 75 0.7× 103 1.5× 40 1.0× 19 409
Sara Droetto Italy 11 278 1.4× 59 0.6× 71 0.7× 124 1.7× 33 0.8× 11 492
Jeff Bailey United States 15 414 2.0× 94 0.9× 135 1.3× 57 0.8× 31 0.8× 26 636
Eric C. Yang Canada 8 182 0.9× 132 1.2× 39 0.4× 92 1.3× 34 0.9× 14 411
Xiaoman Lewis United States 7 358 1.8× 83 0.8× 145 1.4× 60 0.8× 31 0.8× 9 501
Peter Haviernik United States 13 297 1.5× 88 0.8× 58 0.6× 93 1.3× 79 2.0× 25 441
Peter J. Schnorr United States 6 122 0.6× 121 1.1× 57 0.5× 177 2.5× 14 0.4× 8 371
Katia Zavaglia Italy 13 224 1.1× 127 1.2× 93 0.9× 51 0.7× 95 2.4× 23 443
Dailia B. Francis United States 4 323 1.6× 98 0.9× 58 0.6× 31 0.4× 90 2.3× 5 403
Hidetada Kawana Japan 8 175 0.9× 130 1.2× 31 0.3× 47 0.7× 63 1.6× 17 350

Countries citing papers authored by Thomas D. Southgate

Since Specialization
Citations

This map shows the geographic impact of Thomas D. Southgate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas D. Southgate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas D. Southgate more than expected).

Fields of papers citing papers by Thomas D. Southgate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas D. Southgate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas D. Southgate. The network helps show where Thomas D. Southgate may publish in the future.

Co-authorship network of co-authors of Thomas D. Southgate

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas D. Southgate. A scholar is included among the top collaborators of Thomas D. Southgate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas D. Southgate. Thomas D. Southgate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Martinez-Fleites, C., et al.. (2020). The role of small molecules in cell and gene therapy. RSC Medicinal Chemistry. 12(3). 330–352. 12 indexed citations
2.
Southgate, Thomas D., Fernanda Castro, Andrzej Rutkowski, et al.. (2010). CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells. PLoS ONE. 5(4). e9982–e9982. 40 indexed citations
3.
Elkord, Eyad, Adam Dangoor, Deborah J. Burt, et al.. (2009). Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4). Cancer Immunology Immunotherapy. 58(10). 1657–1667. 22 indexed citations
5.
Southgate, Thomas D., Kurt M. Kroeger, Chunyan Liu, Pedro R. Löwenstein, & María G. Castro. (2008). Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors. Current Protocols in Neuroscience. 45(1). 27 indexed citations
6.
Brown, Craig, et al.. (2007). A Cancer Cell-Specific Inducer of Apoptosis. Human Gene Therapy. 18(6). 547–561. 9 indexed citations
7.
Cowen, Rachel, et al.. (2007). Hypoxia‐targeted over‐expression of carboxylesterase as a means of increasing tumour sensitivity to irinotecan (CPT‐11). The Journal of Gene Medicine. 9(4). 244–252. 9 indexed citations
8.
Spencer, Helen, Catherine L.R. Merry, Thomas D. Southgate, et al.. (2007). E-Cadherin Inhibits Cell Surface Localization of the Pro-Migratory 5T4 Oncofetal Antigen in Mouse Embryonic Stem Cells. Molecular Biology of the Cell. 18(8). 2838–2851. 87 indexed citations
9.
Southgate, Thomas D., et al.. (2006). Dual agent chemoprotection by retroviral co‐expression of either MDR1 or MRP1 with the P140K mutant of O6‐methylguanine‐DNA‐methyl transferase. The Journal of Gene Medicine. 8(8). 972–979. 8 indexed citations
10.
Southgate, Thomas D., Michael D. Milsom, Timothy H. Ward, et al.. (2006). Radioprotective gene therapy through retroviral expression of manganese superoxide dismutase. The Journal of Gene Medicine. 8(5). 557–565. 17 indexed citations
12.
Southgate, Thomas D. & Leslie J. Fairbairn. (2004). Genetic manipulation of drug sensitivity in haematopoietic cells. Expert Reviews in Molecular Medicine. 6(18). 1–24. 1 indexed citations
13.
Castro, María G., Thomas D. Southgate, & Pedro R. Löwenstein. (2001). Molecular therapy in a model neuroendocrine disease: developing clinical gene therapy for pituitary tumours. Trends in Endocrinology and Metabolism. 12(2). 58–64. 13 indexed citations
14.
Southgate, Thomas D., Paul A. Kingston, & María G. Castro. (2000). Gene Transfer into Neural Cells In Vitro Using Adenoviral Vectors. Current Protocols in Neuroscience. 13(1). Unit 4.23–Unit 4.23. 58 indexed citations
15.
Southgate, Thomas D., Lynette D. Fairbanks, Adrián E. Morelli, et al.. (1999). Adenoviruses Encoding HPRT Correct Biochemical Abnormalities of HPRT-Deficient Cells and Allow Their Survival in Negative Selection Medium. Metabolic Brain Disease. 14(4). 205–221. 14 indexed citations
16.
Lowenstein, P R, Thomas D. Southgate, Joseph R. Smith-Arica, J. Morrison Smith, & María G. Castro. (1998). Chapter 33 Gene therapy for inherited neurological disorders: Towards therapeutic intervention in the Lesch-Nyhan syndrome. Progress in brain research. 117. 485–501. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026